Avenue Therapeutics (ATXI) Insider Trading & Ownership

$4.78
+0.01 (+0.21%)
(As of 05/3/2024 ET)

Avenue Therapeutics (NASDAQ:ATXI) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.80%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$552,258.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get ATXI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Avenue Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ATXI Insider Buying and Selling by Quarter

Avenue Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/8/2023Fortress Biotech, Inc.Major ShareholderBuy5,578$54.00$301,212.00  
9/8/2023Lindsay A Md RosenwaldDirectorBuy4,649$54.00$251,046.00  
(Data available from 1/1/2013 forward)

ATXI Insider Trading Activity - Frequently Asked Questions

Who is on Avenue Therapeutics's Insider Roster?

The list of insiders at Avenue Therapeutics includes Fortress Biotech, Inc., Joseph Walter Vazzano, Lindsay A Md Rosenwald, and Neil Herskowitz. Learn more on insiders at ATXI.

What percentage of Avenue Therapeutics stock is owned by insiders?

1.80% of Avenue Therapeutics stock is owned by insiders. Learn more on ATXI's insider holdings.

Which Avenue Therapeutics insiders have been buying company stock?

The following insiders have purchased ATXI shares in the last 24 months: Fortress Biotech, Inc. ($301,212.00), and Lindsay A Md Rosenwald ($251,046.00).

How much insider buying is happening at Avenue Therapeutics?

Insiders have purchased a total of 10,227 ATXI shares in the last 24 months for a total of $552,258.00 bought.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:ATXI) was last updated on 5/5/2024 by MarketBeat.com Staff

From Our Partners